NovoCure (NVCR) SEC Filings & 10K Form

$16.82

-0.06 (-0.36%)

(As of 10:07 AM ET)

Compare

Recent NovoCure SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
09/03/2024 6:00 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
08/06/2024 3:16 PM	NovoCure (Issuer) Puri Michal Nath (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
08/06/2024 3:17 PM	Leonard Frank X (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
08/06/2024 3:19 PM	Cordova Ashley (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
08/06/2024 3:19 PM	Danziger Asaf (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
07/25/2024 7:19 AM	NovoCure (Filer)	Form S-8 POS
07/25/2024 7:20 AM	NovoCure (Filer)	Form S-8 POS
Get the Latest News and Ratings for NVCR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for NovoCure and its competitors with MarketBeat's FREE daily newsletter.
07/25/2024 7:21 AM	NovoCure (Filer)	Form S-8 POS
07/25/2024 7:22 AM	NovoCure (Filer)	Form S-8 POS
07/25/2024 7:24 AM	NovoCure (Filer)	Form S-8 POS
07/25/2024 7:25 AM	NovoCure (Filer)	Form S-8 POS
07/25/2024 7:16 AM	NovoCure (Filer)	Form S-8 POS
07/25/2024 7:17 AM	NovoCure (Filer)	Form S-8 POS
07/25/2024 7:18 AM	NovoCure (Filer)	Form S-8 POS
07/25/2024 6:01 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
07/25/2024 6:05 AM	NovoCure (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
07/10/2024 12:14 PM	NovoCure (Subject) VANGUARD GROUP INC (Filed by)	Form SC 13G/A
07/08/2024 3:32 PM	BlackRock Inc. (Filed by) NovoCure (Subject)	Form SC 13G/A
06/06/2024 5:37 PM	NovoCure (Issuer) Ocean Allyson J (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/06/2024 5:13 PM	Madden Martin J. (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/06/2024 4:55 PM	Hung David (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/06/2024 4:42 PM	LEUNG GABRIEL (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
06/06/2024 4:42 PM	NovoCure (Issuer) Scannell Timothy J (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/06/2024 4:43 PM	NovoCure (Issuer) VERNON W ANTHONY (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/06/2024 4:43 PM	NovoCure (Issuer) Stafford Kristin (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
06/06/2024 4:09 PM	HILLEMAN JERYL L (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
05/20/2024 7:01 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/02/2024 6:01 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
05/02/2024 6:01 AM	NovoCure (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
03/27/2024 6:00 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
03/04/2024 5:39 PM	NovoCure (Subject) Shah Pritesh (Reporting)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
03/01/2024 5:17 PM	GROENHUYSEN WILHELMUS CM (Reporting) NovoCure (Subject)	Form 144 Notice of proposed sale of securities pursuant to Rule 144
02/29/2024 3:43 PM	Cordova Ashley (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/29/2024 3:33 PM	Giladi Moshe (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/29/2024 3:33 PM	Leupin Nicolas (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
02/29/2024 3:35 PM	NovoCure (Issuer) Weinberg Uri (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
02/22/2024 6:11 AM	NovoCure (Filer)	Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans
02/22/2024 6:05 AM	NovoCure (Filer)	Form 10-K Annual report pursuant to Section 13 or 15(d)
02/22/2024 6:06 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
02/09/2024 8:28 AM	FMR LLC (Filed by) NovoCure (Subject)	Form SC 13G/A
01/18/2024 6:01 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
The solution to fast food’s wage hike crisis (Ad) Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032. Learn more about this much-needed advancement and investment opportunity here.
01/12/2024 3:57 PM	Leonard Frank X (Reporting) NovoCure (Issuer)	Form 3 Initial statement of beneficial ownership of securities
01/11/2024 4:15 PM	Leupin Nicolas (Reporting) NovoCure (Issuer)	Form 3 Initial statement of beneficial ownership of securities
01/09/2024 6:00 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
01/08/2024 6:10 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
01/04/2024 3:10 PM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
12/20/2023 3:23 PM	Giladi Moshe (Reporting) NovoCure (Issuer)	Form 3 Initial statement of beneficial ownership of securities
12/11/2023 5:19 AM	Capital World Investors (Filed by) NovoCure (Subject)	Form SC 13G/A
11/28/2023 6:30 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)
11/09/2023 5:15 AM	BAILLIE GIFFORD & CO (Filed by) NovoCure (Subject)	Form SC 13G/A
11/08/2023 3:22 PM	NovoCure (Issuer) Shah Pritesh (Reporting)	Form 4 Statement of changes in beneficial ownership of securities
11/02/2023 4:15 PM	NovoCure (Issuer) Puri Michal Nath (Reporting)	Form 3 Initial statement of beneficial ownership of securities
11/02/2023 3:20 PM	Cordova Ashley (Reporting) NovoCure (Issuer)	Form 4 Statement of changes in beneficial ownership of securities
10/26/2023 6:02 AM	NovoCure (Filer)	Form 10-Q General form for quarterly reports under Section 13 or 15(d)
10/26/2023 6:03 AM	NovoCure (Filer)	Form 8-K Current report pursuant to Section 13 or 15(d)